Il y a eu 50 transactions d'initiés récentes enregistrées pour Denali Therapeutics Inc. (DNLI), dont 15 achats et 31 ventes. Le total des achats d'initiés s'élève à $18.74M et le total des ventes d'initiés à $6.73M.
Les initiés notables ayant une activité récente comprennent Watts Ryan J., Schuth Alexander O., Baker Bros. Advisors Lp. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — DNLI
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-01-06 |
Watts Ryan J. |
President and CEO |
Vente Informative |
35,198 |
$16.50 |
$580.77K |
296,833 |
| 2026-01-06 |
Schuth Alexander O. |
Cofo and Secretary |
Vente Informative |
17,218 |
$16.50 |
$284.1K |
282,828 |
| 2026-01-03 |
Watts Ryan J. |
President and CEO |
Attribution de RSU |
236,880 |
$16.27 |
$3.85M |
236,880 |
| 2026-01-03 |
Schuth Alexander O. |
Cofo and Secretary |
Attribution de RSU |
173,100 |
$16.27 |
$2.82M |
173,100 |
| 2025-12-11 |
Baker Bros. Advisors Lp |
Director |
Achat Informatif |
190,523 |
$0.01 |
$1.91K |
2,335,469 |
| 2025-11-04 |
Van Hauwermeiren Timothy |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-11-04 |
Van Hauwermeiren Timothy |
Director |
Attribution de RSU |
10,632 |
- |
- |
10,632 |
| 2025-09-03 |
Watts Ryan J. |
President and CEO |
Don (Donné) |
50,000 |
- |
- |
2,152,604 |
| 2025-08-13 |
Ho Carole |
Chief Medical Officer |
Vente Informative |
806 |
$14.64 |
$11.8K |
216,585 |
| 2025-08-12 |
Schuth Alexander O. |
Cofo and Secretary |
Vente Informative |
2,937 |
$13.58 |
$39.88K |
242,346 |
| 2025-08-12 |
Ho Carole |
Chief Medical Officer |
Vente Informative |
2,937 |
$13.58 |
$39.88K |
217,391 |
| 2025-08-05 |
Ho Carole |
Chief Medical Officer |
Exercice d'Options (Vente) |
44,655 |
$0.68 |
$30.37K |
62,500 |
| 2025-07-09 |
Watts Ryan J. |
President and CEO |
Exercice d'Options (Vente) |
40,000 |
$5.28 |
$211.2K |
20,369 |
| 2025-06-03 |
Baker Julian |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-06-03 |
Flatley Jay T |
Director |
Attribution de RSU |
6,037 |
- |
- |
16,220 |
| 2025-06-03 |
Baker Bros. Advisors Lp |
Director |
Inconnu |
23,901,119 |
$0.01 |
$239.01K |
- |
| 2025-06-03 |
Baker Bros. Advisors Lp |
Director |
Attribution de RSU |
31,695 |
$13.93 |
$441.51K |
31,695 |
| 2025-06-03 |
Tessier-lavigne Marc |
Director |
Attribution de RSU |
18,111 |
$13.93 |
$252.29K |
18,111 |
| 2025-06-03 |
Klein Peter S |
Director |
Attribution de RSU |
18,111 |
$13.93 |
$252.29K |
18,111 |
| 2025-06-03 |
Schenkein David P |
Director |
Attribution de RSU |
6,037 |
- |
- |
15,257 |
| 2025-06-03 |
Krognes Steve E. |
Director |
Attribution de RSU |
18,111 |
$13.93 |
$252.29K |
18,111 |
| 2025-06-03 |
Cook Jennifer E. |
Director |
Attribution de RSU |
18,111 |
$13.93 |
$252.29K |
18,111 |
| 2025-06-03 |
Thornberry Nancy |
Director |
Attribution de RSU |
18,111 |
$13.93 |
$252.29K |
18,111 |
| 2025-01-07 |
Krognes Steve E. |
Director |
Vente Informative |
3,339 |
$20.81 |
$69.48K |
25,757 |
| 2025-01-07 |
Watts Ryan J. |
President and CEO |
Vente Informative |
7,650 |
$20.81 |
$159.2K |
253,071 |
| 2025-01-07 |
Schuth Alexander O. |
Cofo and Secretary |
Vente Informative |
2,907 |
$20.81 |
$60.49K |
244,308 |
| 2025-01-07 |
Ho Carole |
Chief Medical Officer |
Vente Informative |
2,907 |
$20.81 |
$60.49K |
175,673 |
| 2025-01-06 |
Watts Ryan J. |
President and CEO |
Vente Informative |
29,266 |
$20.22 |
$591.76K |
260,721 |
| 2025-01-06 |
Schuth Alexander O. |
Cofo and Secretary |
Vente Informative |
12,255 |
$20.22 |
$247.8K |
247,215 |
| 2025-01-06 |
Ho Carole |
Chief Medical Officer |
Vente Informative |
12,255 |
$20.22 |
$247.8K |
178,580 |
| 2025-01-03 |
Watts Ryan J. |
President and CEO |
Attribution de RSU |
162,540 |
$21.26 |
$3.46M |
162,540 |
| 2025-01-03 |
Schuth Alexander O. |
Cofo and Secretary |
Attribution de RSU |
162,540 |
$21.26 |
$3.46M |
162,540 |
| 2025-01-03 |
Ho Carole |
Chief Medical Officer |
Attribution de RSU |
162,540 |
$21.26 |
$3.46M |
162,540 |
| 2025-01-02 |
Sato Vicki L |
Director |
Vente Informative |
3,080 |
$20.91 |
$64.4K |
107,976 |
| 2024-12-31 |
Krognes Steve E. |
Director |
Vente Informative |
30,000 |
$20.25 |
$607.5K |
29,096 |
| 2024-12-27 |
Schuth Alexander O. |
Cofo and Secretary |
Exercice d'Options (Vente) |
6,708 |
$5.28 |
$35.42K |
46,671 |
| 2024-11-25 |
Ho Carole |
Chief Medical Officer |
Exercice d'Options (Vente) |
17,845 |
$0.68 |
$12.13K |
107,155 |
| 2024-11-22 |
Schuth Alexander O. |
Cofo and Secretary |
Exercice d'Options (Vente) |
20,516 |
$0.68 |
$13.95K |
124,562 |
| 2024-11-11 |
Schenkein David P |
Director |
Exercice d'Options (Vente) |
47,165 |
$18.00 |
$848.97K |
- |
| 2024-11-07 |
Sato Vicki L |
Director |
Vente Informative |
1,020 |
$30.00 |
$30.6K |
111,056 |
| 2024-11-07 |
Schuth Alexander O. |
Cofo and Secretary |
Exercice d'Options (Vente) |
15,558 |
$5.28 |
$82.15K |
53,379 |
| 2024-11-01 |
Sato Vicki L |
Director |
Vente Informative |
3,080 |
$27.07 |
$83.38K |
112,076 |
| 2024-10-18 |
Watts Ryan J. |
President and CEO |
Vente Informative |
40,000 |
$27.69 |
$1.11M |
235,807 |
| 2024-09-30 |
Krognes Steve E. |
Director |
Vente Informative |
30,000 |
$29.03 |
$870.9K |
29,096 |
| 2024-09-13 |
Sato Vicki L |
Director |
Vente Informative |
1,020 |
$30.00 |
$30.6K |
115,156 |
| 2024-09-03 |
Sato Vicki L |
Director |
Vente Informative |
100 |
$25.37 |
$2.54K |
116,176 |
| 2024-08-21 |
Schuth Alexander O. |
Cofo and Secretary |
Vente Informative |
2,547 |
$24.78 |
$63.11K |
178,066 |
| 2024-08-21 |
Ho Carole |
Chief Medical Officer |
Vente Informative |
5,907 |
$24.96 |
$147.44K |
118,810 |
| 2024-08-20 |
Krognes Steve E. |
Director |
Vente Informative |
1,727 |
$23.79 |
$41.09K |
32,677 |
| 2024-08-20 |
Watts Ryan J. |
President and CEO |
Vente Informative |
2,260 |
$23.79 |
$53.77K |
235,807 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
